Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

Chad D. Markert; Anthony Atala; Jennifer K. Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K. Childers

doi:10.1016/j.pmrj.2009.02.013

Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

Chad D. Markert, Anthony Atala, Jennifer K. Cann, George Christ, Mark Furth, Fabrisia Ambrosio, Martin K. Childers

Surgery

Research output: Contribution to journal › Review article

32 Scopus citations

Abstract

Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the bone marrow, distinct from blood-forming stem cells. Based on the embryologic derivation, availability, and various pro-regenerative characteristics, research exploring their use in cell therapy shows great promise for patients with degenerative muscle diseases and a number of other conditions. In this review, the authors explore the potential for mesenchymal stem cell therapy in the emerging field of regenerative medicine with a focus on treatment for Duchenne muscular dystrophy.

Original language	English (US)
Pages (from-to)	547-559
Number of pages	13
Journal	PM and R
Volume	1
Issue number	6
DOIs	https://doi.org/10.1016/j.pmrj.2009.02.013
State	Published - Jun 2009

ASJC Scopus subject areas

Physical Therapy, Sports Therapy and Rehabilitation
Rehabilitation
Neurology
Clinical Neurology

Access to Document

10.1016/j.pmrj.2009.02.013

Fingerprint Dive into the research topics of 'Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy'. Together they form a unique fingerprint.

Cite this

Markert, C. D., Atala, A., Cann, J. K., Christ, G., Furth, M., Ambrosio, F., & Childers, M. K. (2009). Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy. PM and R, 1(6), 547-559. https://doi.org/10.1016/j.pmrj.2009.02.013

@article{9deaad308adf47a0a4d4f5f818256677,

title = "Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy",

abstract = "Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the bone marrow, distinct from blood-forming stem cells. Based on the embryologic derivation, availability, and various pro-regenerative characteristics, research exploring their use in cell therapy shows great promise for patients with degenerative muscle diseases and a number of other conditions. In this review, the authors explore the potential for mesenchymal stem cell therapy in the emerging field of regenerative medicine with a focus on treatment for Duchenne muscular dystrophy.",

author = "Markert, {Chad D.} and Anthony Atala and Cann, {Jennifer K.} and George Christ and Mark Furth and Fabrisia Ambrosio and Childers, {Martin K.}",

year = "2009",

month = jun,

doi = "10.1016/j.pmrj.2009.02.013",

language = "English (US)",

volume = "1",

pages = "547--559",

journal = "PM and R",

issn = "1934-1482",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Mesenchymal Stem Cells

T2 - Emerging Therapy for Duchenne Muscular Dystrophy

AU - Markert, Chad D.

AU - Atala, Anthony

AU - Cann, Jennifer K.

AU - Christ, George

AU - Furth, Mark

AU - Ambrosio, Fabrisia

AU - Childers, Martin K.

PY - 2009/6

Y1 - 2009/6

N2 - Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the bone marrow, distinct from blood-forming stem cells. Based on the embryologic derivation, availability, and various pro-regenerative characteristics, research exploring their use in cell therapy shows great promise for patients with degenerative muscle diseases and a number of other conditions. In this review, the authors explore the potential for mesenchymal stem cell therapy in the emerging field of regenerative medicine with a focus on treatment for Duchenne muscular dystrophy.

AB - Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the bone marrow, distinct from blood-forming stem cells. Based on the embryologic derivation, availability, and various pro-regenerative characteristics, research exploring their use in cell therapy shows great promise for patients with degenerative muscle diseases and a number of other conditions. In this review, the authors explore the potential for mesenchymal stem cell therapy in the emerging field of regenerative medicine with a focus on treatment for Duchenne muscular dystrophy.

UR - http://www.scopus.com/inward/record.url?scp=67249147702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249147702&partnerID=8YFLogxK

U2 - 10.1016/j.pmrj.2009.02.013

DO - 10.1016/j.pmrj.2009.02.013

M3 - Review article

C2 - 19627945

AN - SCOPUS:67249147702

VL - 1

SP - 547

EP - 559

JO - PM and R

JF - PM and R

SN - 1934-1482

IS - 6

ER -